UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019610
Receipt No. R000022188
Scientific Title Multicenter randomized controlled trial of endoscopic treatment for conventional bile duct stone:ordinary sphincterotomy vs.papillary balloon dilation with minor sphincterotomy
Date of disclosure of the study information 2015/11/02
Last modified on 2022/11/08 (Ver. 14)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multicenter randomized controlled trial of endoscopic treatment for conventional bile duct stone:ordinary sphincterotomy vs.papillary balloon dilation with minor sphincterotomy
Acronym Multicenter randomized controlled trial of endoscopic treatment for conventional bile duct stone:ordinary sphincterotomy vs.papillary balloon dilation with minor sphincterotomy
Scientific Title Multicenter randomized controlled trial of endoscopic treatment for conventional bile duct stone:ordinary sphincterotomy vs.papillary balloon dilation with minor sphincterotomy
Scientific Title:Acronym Multicenter randomized controlled trial of endoscopic treatment for conventional bile duct stone:ordinary sphincterotomy vs.papillary balloon dilation with minor sphincterotomy
Region
Japan

Condition
Condition Bile duct stones
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the utility and safety between the ordinary sphincterotomy and the minor sphincterotomy with balloon dilation in the ensoscopic treatment for common bile duct stones of <= 12 mm in diameter.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes The necessity of mechanical lithotripsy
Key secondary outcomes Fluoroscopy time, procedure time, complete stome removal, and
complications.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation
Institution consideration
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 ordinary sphincterotomy
Interventions/Control_2 papillary balloon dilation with minor sphincterotomy
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Untreated Duodenum main
2)Bile duct stones of <= 12 mm
3)Written informed concent
Key exclusion criteria 1)Severe bleeding tendency
2)Post-operation of stomach, duodenum, bile duct
3)Non-adaptive case of endoscopic procedure
4)Other problem(s) in the opinion of the Investigator(s)
Target sample size 220

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Hisa
Organization Saku Central Hospital Advanced Care Center
Division name Gastroenterology
Zip code 385-0051
Address Nakagomi 3400-28, Saku, Nagano 385-0051 Japan
TEL 0267-62-8181
Email hisa.takeshi@sakuhp.or.jp

Public contact
Name of contact person
1st name Miyuki
Middle name
Last name Niimi
Organization Saku Central Hospital Advanced Care Center
Division name Clinical Research Center
Zip code 385-0051
Address 3400-28 Nakagomi, Saku, Nagano 385-0051 JAPAN
TEL 0267-62-8181
Homepage URL
Email ctroffice@sakuhp.or.jp

Sponsor
Institute Saku Central Hospital Advanced Care Center
Institute
Department

Funding Source
Organization Shinshu Public Utility Foundation for Promotion of Medical Sciences
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Saku Central Hospital Group Research Ethics Committee
Address 197 Usuda, Saku, Nagano,384-0393 JAPAN
Tel 0267-82-3131
Email irboffice@sakuhp.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 帯広厚生病院(北海道)

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 08 Month 25 Day
Date of IRB
2015 Year 09 Month 04 Day
Anticipated trial start date
2015 Year 10 Month 05 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
2021 Year 03 Month 31 Day
Date trial data considered complete
2021 Year 04 Month 16 Day
Date analysis concluded
2022 Year 06 Month 30 Day

Other
Other related information

Management information
Registered date
2015 Year 11 Month 02 Day
Last modified on
2022 Year 11 Month 08 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022188